Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

October NICE Guidance

The National Institute of Health and Clinical Excellence has published new guidance for the month of October.

There are two guidance documents that have an impact in primary care. A technology appraisal recommends (QRG) that prasugrel (Efient®) is an option in combination with aspirin for patients who are treated by percutaneous coronary intervention following an acute coronary syndrome. This applies only when they have had a ST-segment-elevation myocardial infarction (STEMI), have had a blocked stent while on treatment with clopidogrel or have diabetes. The Summary of Product Characteristics recommends treatment continues for up to 12 months unless discontinuation is clinically indicated at an earlier time, perhaps due to side effects.

There is also a clinical guideline that covers the treatment and management of depression in adults (QRG). This is an update of an existing guideline and is published along with a summary guideline that contains information relevant to general hospital settings. A stepped approach is recommended with higher intensity therapies recommended for more severe cases.

Action: Clinicians who are involved in the treatment of adults with depression or who provide continuing care for patients after an acute coronary syndrome should consider these guidelines to be required reading.

Share 'October NICE Guidance' on Email Share 'October NICE Guidance' on Delicious Share 'October NICE Guidance' on Digg Share 'October NICE Guidance' on Facebook Share 'October NICE Guidance' on Google+ Share 'October NICE Guidance' on reddit Share 'October NICE Guidance' on StumbleUpon Share 'October NICE Guidance' on Twitter

atomic-wealth

No Comments to “October NICE Guidance”

Leave a Comment

(required)

(required)


Prescribing Advice for GPs is powered by WordPress.
Subscribe for Free to our RSS or Atom Feeds for New Entries.
Akismet has protected Prescribing Advice for GPs from 789,670 spam comments.

atomic-wealth
fond-illness
summer